Robert Barrow sold $722K of Definium Therapeutics (DFTX)

Executed Sep 3, disclosed Sep 5, 1 day later.

Value, as filed

$722K

19,023 sh × $37.94

Executed

Sep 3

the trade date, as filed

Disclosed

Sep 5

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

RB Robert Barrow Chief Executive Officer profile →

Robert Barrow (Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in MNMD. The largest single filing was $1.3M of DFTX (29,208 sh × $45.03, as filed), executed Jun 25.

The name

DFTX Definium Therapeutics, Inc. DFTX · Healthcare · 9 filings in 24 months ticker →

Healthcare · Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Robert Barrow in DFTX

DFTXSALE Definium Therapeutics, Inc. $1.3M
29,208 sh × $45.03
Exec Jun 25
Filed Jun 26 · 5:30 PM ET DFTXSALE Definium Therapeutics, Inc. $451K
24,431 sh × $18.47
Exec Mar 25
Filed Mar 26 · 5:30 PM ET